Phage Therapy as an Alternative Strategy Against Pseudomonas aeruginosa : A Narrative Review of Preclinical and Clinical Evidence
MicrobiologyOpen · 2026
DOI: 10.1002/mbo3.70303 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MicrobiologyOpen, 2026. Verfasst von Gustavo Aparecido da Cunha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Federal University of Alfenas, Alfenas, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Phage Therapy, Pseudomonas aeruginosa, Pseudomonas Infections, Pseudomonas Phages. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), The Coordenação de Aperfeiçoamento de Pessoal de Nivel Superior, Brazil (CAPES), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Grants Number.
Abstract (Originalsprache)
Pseudomonas aeruginosa is an opportunistic pathogen and one of the main causes of nosocomial infections. This pathogen affects immunocompromised individuals such as patients with chronic wounds or cystic fibrosis. Its capacity to evade antimicrobial therapies through resistance mechanisms has resulted in widespread prevalence of multidrug‐resistant (MDR), extensively drug‐resistant (XDR), and pandrug‐resistant (PDR) strains. We searched three databases (PubMed/Medline, Scopus, and Web of Science) for articles evaluating the effects of phage administration in the management of P. aeruginosa infections in animals and humans. We analyzed the main characteristics of the interventions, the coverage of different bacterial strains, and discussed possible gaps in the evidence available in the last 10 years. Literature shows strong evidence that the use of phage therapy for several clinical conditions in humans and animal models is a safe and effective intervention for infections caused by MDR/XDR/PDR P. aeruginosa . Despite its therapeutic potential, phage therapy still faces several limitations such as lack of standardized dosing protocols, inconsistent endotoxin quantification, and limited regulatory frameworks. Future guidelines should focus on the regulation and validation of phage therapy in clinical practice, after overcoming the limitations currently identified. Further studies should ensure the standardization of phage production and the validation of delivery systems and routes of administration. Conducting multicenter clinical trials can contribute to the clinical implementation of phage therapy in countries where it is not yet regulated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Federal University of Alfenas, Alfenas, Minas Gerais, Brazil.
- The Norwegian College of Fishery Science, Faculty of Biosciences, Fisheries and Economics, UiT - The Arctic University of Norway, Tromsø, Norway.
ORCID-Profile: Gustavo Aparecido da Cunha, Luiz Cosme Cotta Malaquias
Förderung
- Fundação de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)
- The Coordenação de Aperfeiçoamento de Pessoal de Nivel Superior, Brazil (CAPES)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Grants Number
- Centre for New Antibacterial Strategies [CANS] of the Arctic University of Norway project ID
Zitieren
APA
Cunha, G. A. D., Amaral, R. P., Dos Santos, A. L. C., Aio, B. R. F., Durante, M. F. R., Malaquias, L. C. C., de Freitas Almeida, G. M., & Coelho, L. F. L. (2026). Phage Therapy as an Alternative Strategy Against Pseudomonas aeruginosa : A Narrative Review of Preclinical and Clinical Evidence. MicrobiologyOpen. https://doi.org/10.1002/mbo3.70303
Vancouver
Cunha GAD, Amaral RP, Dos Santos ALC, Aio BRF, Durante MFR, Malaquias LCC, et al. Phage Therapy as an Alternative Strategy Against Pseudomonas aeruginosa : A Narrative Review of Preclinical and Clinical Evidence. MicrobiologyOpen. 2026. doi:10.1002/mbo3.70303
BibTeX
@article{Cunha2026,
author = {Cunha, Gustavo Aparecido da and Amaral, Raine Piva and Dos Santos, Ana Luisa Cauvila and Aio, Bárbara Rafaela Ferreira and Durante, Maria Fernanda Romboli and Malaquias, Luiz Cosme Cotta and de Freitas Almeida, Gabriel Magno and Coelho, Luiz Felipe Leomil},
title = {Phage Therapy as an Alternative Strategy Against Pseudomonas aeruginosa : A Narrative Review of Preclinical and Clinical Evidence},
journal = {MicrobiologyOpen},
year = {2026},
doi = {10.1002/mbo3.70303}
}
EUVIMED